Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. brain data
Show results for
Products
Services
Software

Companies

News
Articles
Books
Videos

Refine by
Date

  • Older

Brain Data Articles & Analysis: Older

20 news found

EMOTIV Enlists Two Machine Learning Heavyweights as AI Takes Aim at the Human Brain

EMOTIV Enlists Two Machine Learning Heavyweights as AI Takes Aim at the Human Brain

Flake as CTO of Search and Data Science. At EMOTIV, Dr. Rickard will focus on building large/advanced brain models and directing the AI/ML team. ...

ByEmotiv Inc.


xCures presents clinical and translational research with two posters at the 2022 SNO Annual Meeting

xCures presents clinical and translational research with two posters at the 2022 SNO Annual Meeting

“Together with leading neuro-oncologists and computational biologists, we are bringing evidence-based insights to the treatment of brain cancer patients.” The xCures platform generates Real-time, Regulatory-grade, Clinical data (RRC). It now includes data on over 1,000 brain cancer patients, permitting real-time ...

ByxCures


Oxford Brain Diagnostics’ grey matter quality measure selected as secondary outcome for Alzheimer’s Phase 2 clinical trial

Oxford Brain Diagnostics’ grey matter quality measure selected as secondary outcome for Alzheimer’s Phase 2 clinical trial

In the future, we hope this type of biomarker response will help predict a therapeutic benefit long before clinical benefits can be measured.” Oxford Brain Diagnostics Ltd is rethinking how brain health is assessed and managed. Founded in neuropathological and neuroimaging expertise, the company’s patented Cortical Disarray Measurement (CDM®) ...

ByOxford Brain Diagnostics Ltd.


Forge Reports Positive Clinical Data on Brain Development and Motor Function from the RESKUE Novel Phase 1/2 Gene Therapy Trial in Patients with Krabbe Disease at the SSIEM Annual Symposium

Forge Reports Positive Clinical Data on Brain Development and Motor Function from the RESKUE Novel Phase 1/2 Gene Therapy Trial in Patients with Krabbe Disease at the SSIEM Annual Symposium

FBX-101 clinical data demonstrating safety and initial efficacy from the RESKUE trial is being presented at the 2022 Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium FBX-101 is a systemic AAV gene therapy following unrelated cord blood transplantation (“UCBT”) and has been well tolerated through Day 180 FBX-101 significantly increased ...

ByForge Biologics, Inc.


Research from Beacon Biosignals Presented at Alzheimer`s Association International Conference

Research from Beacon Biosignals Presented at Alzheimer`s Association International Conference

Medical Director Jay Pathmanathan, MD, PhD, discussed how the company has applied its machine learning platform to standard electroencephalography (EEG) data to detect electrical disturbances in the brain that may predict cognitive decline and explain variability in disease course for patients with Alzheimer's disease. ...

ByBeacon Biosignals, Inc.


Synchron Announces First Human U.S. Brain-Computer Interface Implant

Synchron Announces First Human U.S. Brain-Computer Interface Implant

Synchron, an endovascular brain-computer interface (BCI) company, today announced the first human BCI implant in the United States. ...

BySynchron, Inc.


VeriSIM Life and Total Brain Announce Strategic Collaboration Agreement Applying AI to Develop New Drugs for Neurological Disorders

VeriSIM Life and Total Brain Announce Strategic Collaboration Agreement Applying AI to Develop New Drugs for Neurological Disorders

The company’s data sets represent the world’s largest standardized brain database encompassing human electrical brain function, brain structure and blood flow, inclusive of full genetic assessments. “We are excited to partner with Total Brain to combine the power of their high-dimensional ...

ByVeriSIM Life


Beacon Biosignals announces partnership with Stratus to advance at-home brain monitoring and machine learning-enabled neurodiagnostics

Beacon Biosignals announces partnership with Stratus to advance at-home brain monitoring and machine learning-enabled neurodiagnostics

"Stratus helps solve data capture issues by providing accessible, nationwide testing services that reduce the variability in data collection and help ensure high-quality data across all sites. ...

ByBeacon Biosignals, Inc.


New BESA Research workshop scheduled

New BESA Research workshop scheduled

Basics and advanced methods of M/EEG data analysis in human brain #research will be covered extensively. Briefly, the workshop will include a journey from basic data review and pre-processing through source analysis and source imaging, arriving at connectivity analysis and group statistics. ...

ByBESA GmbH


Neeuro (Singapore) and epihunter (Belgium) partner to create new and innovative digital solutions for people with brain disorders

Neeuro (Singapore) and epihunter (Belgium) partner to create new and innovative digital solutions for people with brain disorders

That pain became a vision, and that vision became the Belgian digital therapeutics company epihunter, aimed at enabling people with a brain disorder to participate more fully in society while generating real world data for faster diagnosis and optimized treatments. ...

ByEpihunter NV


Major Research Findings Highlight Effectiveness of the PrecivityAD™ Blood Test That Clinicians Use to Aid in Alzheimer’s Disease Diagnosis

Major Research Findings Highlight Effectiveness of the PrecivityAD™ Blood Test That Clinicians Use to Aid in Alzheimer’s Disease Diagnosis

A PET scan is the traditional method to determine build-up of amyloid plaques in the brain among people who do not show symptoms of Alzheimer’s disease. ...

ByC2N Diagnostics


Oxford Brain Diagnostics establishes a research-based clinical MRI study in Japan to investigate how Cortical Disarray Measurement (CDM) analysis may support differential diagnosis and estimate disease severity in Dementia patients

Oxford Brain Diagnostics establishes a research-based clinical MRI study in Japan to investigate how Cortical Disarray Measurement (CDM) analysis may support differential diagnosis and estimate disease severity in Dementia patients

This project, led by Oxford Brain Diagnostics and Dr Nakajima, will gather real world MRI patient data, and will use CDM analysis, based on changes at the cellular level, to assess dementia disease severity and potentially support differential diagnosis. ...

ByOxford Brain Diagnostics Ltd.


Synchron receives green light from FDA to begin breakthrough trial of implantable brain computer interface in US

Synchron receives green light from FDA to begin breakthrough trial of implantable brain computer interface in US

Outcomes will include the use of the brain data to control digital devices and achieve improvements in functional independence. ...

BySynchron, Inc.


Oxford Brain Diagnostics wins funding from the National Institute for Health Research (NIHR) to test Alzheimer’s diagnostic in NHS

Oxford Brain Diagnostics wins funding from the National Institute for Health Research (NIHR) to test Alzheimer’s diagnostic in NHS

Dr Steven Chance, CEO, Oxford Brain Diagnostics said ‘we are very excited to be working with our partners and the NIHR on this project. ...

ByOxford Brain Diagnostics Ltd.


Neurolutions IpsiHand Stroke Rehabilitation Device Authorized by FDA

Neurolutions IpsiHand Stroke Rehabilitation Device Authorized by FDA

A stroke occurs when normal blood flow to the brain is interrupted. Brain cells obtain oxygen and nutrients from regular blood circulation, so when there is a blockage of blood flow to the brain caused by a clot (an ischemic stroke) or excessive bleeding in the brain due to a ruptured blood vessel (a hemorrhagic stroke), the ...

ByNeurolutions


GT Medical Technologies Announces First Patient Treated in Registry Trial of GammaTile Therapy for Brain Tumors

GT Medical Technologies Announces First Patient Treated in Registry Trial of GammaTile Therapy for Brain Tumors

This will be the first observational registry study of resection plus GammaTile. Data from the study will be used to benchmark clinical outcomes for GammaTile Therapy and allow for comparisons to existing standard-of-care treatments for patients with brain tumors. Over 700,000 Americans are living with a brain tumor today.1 Despite the efforts ...

ByGT Medical Technologies, Inc.


Oxford Brain Diagnostics awarded FDA Breakthrough Device Designation for technology to predict Alzheimer’s Disease

Oxford Brain Diagnostics awarded FDA Breakthrough Device Designation for technology to predict Alzheimer’s Disease

CDM technology uses noninvasive MRI brain scan data linked to changes in the brain at a cellular level, offering sensitive and accurate assessment of the neurodegeneration associated with Alzheimer’s disease and other dementias. ...

ByOxford Brain Diagnostics Ltd.


TIKOMED’S ILB® restores brain energy metabolism following severe traumatic brain injury in the rat demonstrated in data published by the journal Antioxidants

TIKOMED’S ILB® restores brain energy metabolism following severe traumatic brain injury in the rat demonstrated in data published by the journal Antioxidants

A new study on TIKOMED’s lead drug candidate, ILB®, addressing one of the underlying causes of neurodegeneration in acute and chronic diseases was published in Antioxidants today. The data from the rodent model studying severe traumatic brain injury (sTBI), showed that a single post-injury injection of ILB® has beneficial effects on the metabolic ...

ByTIKOMED AB


Artificial Intelligence Expert Neil Sahota Joins Evoke Neuroscience Executive Advisory Board

Artificial Intelligence Expert Neil Sahota Joins Evoke Neuroscience Executive Advisory Board

“His expertise and global perspective are a great fit for where we are headed, and we are grateful to have his guidance as we integrate AI into the eVox platform.” The eVox® Brain Health System is 510(k) cleared to collect neurophysiology data that primary and specialty care physicians use to aid in diagnosis of cognitive disorders. ...

ByEvoke Neuroscience


Manganese inhaled from the shower - A public health threat? maybe

Manganese inhaled from the shower - A public health threat? maybe

In their analysis, Spangler and Elsner found that concentrations well below 0.5 milligrams might lead to brain injury. "Inhaling manganese, rather than eating or drinking it, is far more efficient at delivering manganese to the brain," said Spangler. "The nerve cells involved in smell are a direct pathway for toxins to enter the brain. Once ...

ByFiltronics, Incorporated

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT